Literature DB >> 21983894

Negative impact of low body mass index on surgical outcomes after hepatectomy for hepatocellular carcinoma.

Yukiyasu Okamura1, Atsuyuki Maeda, Kazuya Matsunaga, Hideyuki Kanemoto, Katsuhiko Uesaka.   

Abstract

BACKGROUND: Studies have previously indicated that surgical outcomes are poorer for obese patients. To date, few reports concerning the effect of obesity on patient outcomes following a hepatectomy for hepatocellular carcinoma (HCC) have been published. The present study, therefore, sought to determine the impact of patients' body mass index (BMI, kg/m(2)) on short- and long-term surgical outcomes and to identify potential prognostic factors for HCC following a hepatectomy.
METHODS: Patient data was retrospectively collected from 181 consecutive patients between September 2002 and August 2007 who had undergone hepatectomy for HCC with curative intent. Patients were assigned to three groups according to their BMI (low <18.5, standard 18.5-25, and high >25), and the clinical and pathological data, surgical outcome, and long-term survival were analyzed and compared between the three groups.
RESULTS: The overall survival rate of the low BMI group was notably below that of the standard group. Surgical outcomes were not significantly different between the three groups. Multivariate analysis revealed that a low BMI (<18.5) is a predictor of unfavorable prognosis.
CONCLUSIONS: The present study suggests that a low BMI is a significant prognostic factor for low overall survival when performing a hepatectomy for HCC.

Entities:  

Mesh:

Year:  2012        PMID: 21983894     DOI: 10.1007/s00534-011-0461-y

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Sci        ISSN: 1868-6974            Impact factor:   7.027


  10 in total

1.  Association of standardized liver volume and body mass index with outcomes of minimally invasive liver resections.

Authors:  Darren W Chua; Nicholas Syn; Ye-Xin Koh; Jin-Yao Teo; Peng-Chung Cheow; Alexander Y F Chung; Chung-Yip Chan; Brian K P Goh
Journal:  Surg Endosc       Date:  2022-08-23       Impact factor: 3.453

Review 2.  Hepatocellular carcinoma in non-alcoholic fatty liver disease-a review of an emerging challenge facing clinicians.

Authors:  Daniel Geh; Derek M Manas; Helen L Reeves
Journal:  Hepatobiliary Surg Nutr       Date:  2021-01       Impact factor: 8.265

3.  Obesity Does Not Influence Outcomes in Hepatocellular Carcinoma Patients following Curative Hepatectomy.

Authors:  Zhe Guo; Jun Zhang; Jing-Hang Jiang; Le-Qun Li; Bang-De Xiang
Journal:  PLoS One       Date:  2015-05-12       Impact factor: 3.240

4.  Negative impact of low body mass index on liver cirrhosis patients with hepatocellular carcinoma.

Authors:  Qinggang Li; Hui Xing; Dan Liu; Hui Li
Journal:  World J Surg Oncol       Date:  2015-10-06       Impact factor: 2.754

5.  Body Mass Index and Waistline are Predictors of Survival for Hepatocellular Carcinoma After Hepatectomy.

Authors:  Xiyu Liu; Jiangfeng Xu
Journal:  Med Sci Monit       Date:  2015-07-29

6.  Liver resection in hepatitis B-related hepatocellular carcinoma: clinical outcomes and safety in overweight and obese patients.

Authors:  Haiqing Wang; Jian Yang; Xiaowu Zhang; Lunan Yan; Jiayin Yang
Journal:  PLoS One       Date:  2014-06-10       Impact factor: 3.240

7.  The Association Between Body Mass Index and the Prognosis and Postoperative Complications of Hepatocellular Carcinoma: A Meta-Analysis.

Authors:  Xiaoxiang Rong; Fang Wei; Qian Geng; Jian Ruan; Hongfen Shen; Aimin Li; Rongcheng Luo
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.889

8.  Body mass index and cholesterol level predict surgical outcome in patients with hepatocellular carcinoma in Taiwan - a cohort study.

Authors:  Ya-Ling Lee; Wan-Chun Li; Tung-Hu Tsai; Hsin-Yu Chiang; Chin-Tsung Ting
Journal:  Oncotarget       Date:  2016-04-19

9.  Prognostic Value of Preoperative Prognostic Nutritional Index and Body Mass Index Combination in Patients with Unresectable Hepatocellular Carcinoma After Transarterial Chemoembolization.

Authors:  Shengwei Li; Jin-He Guo; Jian Lu; Chao Wang; Hao Wang
Journal:  Cancer Manag Res       Date:  2021-02-17       Impact factor: 3.989

10.  Effect of early oral nutrition supplement using Encover in patients undergoing hepato-biliary-pancreatic surgery.

Authors:  Byeong Jun Lee; Joon Seong Park; Hyung Sun Kim; Dong Sup Yoon; Jin Hong Lim
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2022-03-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.